跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOMVI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TOMVI
Authorized
STANDARD
TOMVI
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e0416041817115b7
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
e0416041817115b7
Drug Approval Canada Name
TOMVI
Product Name
TOMVI
Status
Marketed
Status Date
2020-09-14
Original Market Date
2020-09-14
Din
02498650
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:04.08
Atc Original
N01AX07 ETOMIDATE
Atc Name
n 01 ax 07
Aig Number
0162234001
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
ETOMIDATE
2 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e0416041817115b7
Type
Standard
Back to Health Canada Approvals